A horse race between Merck and Bristol-Myers Squibb, and the importance of one biomarker, will be a focus at the American Society of Clinical Oncology's annual meeting.
The review does not include North America, the healthcare giant said.
The legislation would allow drugmakers to share economic information with payers beyond what is included on the FDA-approved label.
Either we need to stop calling it digital marketing (because digital is baked into business) and just consider it marketing. If we feel like we can't, then digital might very well be a dead-end job.
Apple is putting the power of clinical trials in our pockets with ResearchKit.
Why healthcare brands need to start speaking in video, and how they can do it